| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/04/2001 | EP1088084A2 Erythropoietin analog-human serum albumin fusion protein |
| 04/04/2001 | EP1088071A1 94 human secreted proteins |
| 04/04/2001 | EP1088067A1 Methods and compositions for modulating spermatogenesis |
| 04/04/2001 | EP1087997A2 Monoclonal antibodies directed against the g3bp protein, and uses |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087992A1 Antithrombotic compounds |
| 04/04/2001 | EP1087991A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 04/04/2001 | EP1087988A1 Meiosis regulating compounds |
| 04/04/2001 | EP1087986A1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087973A1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity |
| 04/04/2001 | EP1087972A1 Triazolo-pyrimidines as ligands for gaba receptors |
| 04/04/2001 | EP1087968A1 Triazolo-pyridine derivatives as ligands for gaba receptors |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087954A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 04/04/2001 | EP1087951A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 04/04/2001 | EP1087950A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | EP1087785A2 Combination of radiotherapy and anti-angiogenic factors |
| 04/04/2001 | EP1087784A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 04/04/2001 | EP1087783A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF $i(HELICOBACTER PYLORI)-ASSOCIATED DISORDERS |
| 04/04/2001 | EP1087782A1 Regulation of tyrosine hydroxylase |
| 04/04/2001 | EP1087779A2 Compositions for increasing energy in vivo |
| 04/04/2001 | EP1087778A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 04/04/2001 | EP1087775A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 04/04/2001 | EP1087771A1 Use of a nk-1 receptor antagonist for treating bipolar disorders |
| 04/04/2001 | EP1087769A1 Use of a pyridazinone derative |
| 04/04/2001 | EP1087766A1 Method of treatment |
| 04/04/2001 | EP1087765A2 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| 04/04/2001 | EP1087764A1 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
| 04/04/2001 | EP1087763A1 Neurotrophic difluoroamide agents |
| 04/04/2001 | EP1087717A1 Improved methods and apparatus for multi-photon photo-activation of therapeutic agents |
| 04/04/2001 | EP1087663A2 Caspases and apoptosis |
| 04/04/2001 | EP1087661A1 Il-8 receptor antagonists |
| 04/04/2001 | EP0954320A4 Inositol polyphosphate derivatives and methods of using same |
| 04/04/2001 | EP0939767A4 Modified factor viii |
| 04/04/2001 | EP0710662B1 Quinolinecarboxylic acid derivative |
| 04/04/2001 | CN1290269A 5'-deoxycytidine derivatives |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290265A Thrombin receptor antagonists |
| 04/04/2001 | CN1290264A Triazine angiogenesis inhibitors |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/04/2001 | CN1290255A Dihydroxyhexanoic acid derivatives |
| 04/04/2001 | CN1290253A Heterocyclic topoisomerase poisons |
| 04/04/2001 | CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/04/2001 | CN1290168A Inhibition of membrane-associated viral replication |
| 04/04/2001 | CN1290166A Treatment of Dyskinesie |
| 04/04/2001 | CN1290165A Benzothiazole Protein tyrosine kinase inhibitors |
| 04/04/2001 | CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas |
| 04/04/2001 | CN1290163A Pharmaceuticals comprising N,N'-BIS(2-Hydroxybenzy) ethylenediamine-N, N'-diacetic acid for iron chelating therapy |
| 04/04/2001 | CN1290161A Nuclear receptor ligands and ligand binding domains |
| 04/04/2001 | CN1289766A Penicillene compounds and derivatives therefrom |
| 04/04/2001 | CN1289618A Health-care polypeptide product for nerve and its preparing process |
| 04/04/2001 | CN1289598A Veterinary medicine for treating infective serositis of duck and its preparing process |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/04/2001 | CN1289591A Medicinal method for exuviating scorpion |
| 04/04/2001 | CN1063953C Drug for curing nephrosis and its preparing method |
| 04/03/2001 | US6211393 Radicals linked to si are si--o--c, si--s--c or si--n--c type bonds and are hydrolyzable in vivo, forming si--oh bonds that are biologically active especially when in contact with living tissue |
| 04/03/2001 | US6211372 Pharmaceutical compositions and methods for use |
| 04/03/2001 | US6211367 Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity |
| 04/03/2001 | US6211364 Process for preparing indane-like compounds |
| 04/03/2001 | US6211362 Pyrroloazepine compounds |
| 04/03/2001 | US6211243 Methods for treating cold sores with anti-infective compositions |
| 04/03/2001 | US6211242 Benzamide derivatives as vasopressin antagonists |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211222 Substituted indazole derivatives and related compounds |
| 04/03/2001 | US6211212 Drugs with amide and ester groups as enzyme inhibitors |
| 04/03/2001 | US6211210 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |
| 04/03/2001 | US6211203 Respiratory system disorders, antiinflammatory agents, enzyme inhibitors |
| 04/03/2001 | US6211201 Multivalent salts of pyridostigmine and related compounds |
| 04/03/2001 | US6211200 Administering zinc chelated imidazo(4,5-d)imidazole compounds as granulocyte colony stimulating factor agonists |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211196 Benzyloxy-substituted, fused N-heterocycles, processes for their preparation, and their use as bradykinin receptor antagonists |
| 04/03/2001 | US6211195 Nervous system, psychological and glandular disorders |
| 04/03/2001 | US6211194 Solution containing nicotine |
| 04/03/2001 | US6211189 Nitric oxide synthase inhibitors; antiinflammatory agents, analgesics |
| 04/03/2001 | US6211187 Post-traumatic stress; antidepressants, anxiolytic agents |
| 04/03/2001 | US6211186 Polyoxyalkylene glycol modified with n-heterocycle derivative with amidine or guanidine group; diaper rash, obesity, acne, periodontal disease, contraceptives; protease and lipase inhibitors |
| 04/03/2001 | US6211183 Selective factor Xa inhibitors |
| 04/03/2001 | US6211182 Histamine h3-antagonists; antiinflammatory agents, antiallergens, antiasthmatics; nervous system, psychological, sleep, and gastrointestinal disorders |
| 04/03/2001 | US6211181 1-Benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211166 Coadministered with a 5-fluorouracil derivative; anticarcinogenic agents |
| 04/03/2001 | US6211164 Sensitization of tumor cells |
| 04/03/2001 | US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus |
| 04/03/2001 | US6211157 Administering bone-derived protein; ultrafiltration, ion exchanging, liquid chromatography |
| 04/03/2001 | US6211152 Formulations for peptide release |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6210974 Compositions and methods for promoting nerve regeneration |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |